Medications account for more than 230,000 admissions to Australian hospitals each year with an estimated cost of $1.2 billion.
The transition of care for patients with chronic and complex diseases from the hospital to the community setting is a critical time with an increased risk of medication misadventure and re-hospitalisation.
A clinical pharmacist integrated into the general practice team collaborating with GPs and other health professionals has the potential to reduce the occurrence of unplanned hospital readmissions due to medication misadventure and increase the likelihood of the patient receiving the intended treatment plan recommended by the hospital team.
Our research team, is led by Dr Chris Freeman who is a clinical lecturer at the University of Queensland and a Consultant Practice Pharmacist at Camp Hill Healthcare. Chris is support by a large and experienced research team made up of researchers, clinicians, statisticians, and health economists.
Oversight and engagement of the project is undertaken by the Stakeholder Reference Group consisting of representatives from key organisations and groups related to primary, tertiary and transition care.
The project staff are led by Dr Holly Foot, Postdoctoral Research Fellow at the University of Queensland and are responsibile for the day to day running of the project.